|
Bhol KC, Alroy J, Schechter PJ. Anti-inflammatory effect of topical nanocrystalline silver cream on allergic contact dermatitis in a guinea pig model. Clin Exp Dermatol. May 2004; 29:282-7.
Bhol KC, Schechter PJ. Suppressive effects of topical nanocrystalline silver on allergic contact dermatitis in mice. Clin & Invest Med. Aug 2004; 27(4): 196A.
Bhol KC, Schechter PJ. Topical nanocrystalline silver cream inhibits expression of matrix metalloproteinase-9 in animal models of allergic contact dermatits. J Invest Dermatol. April 2005; 124(4): A117.
Lyczak JB, Schechter PJ. Nanocrystalline silver inhibits antibiotic-, antiseptic-resistant bacteria. Clin Pharmacol Ther. 2005; 77:60.
Bhol KC, Schechter PJ. Topical nanocrystalline silver cream suppresses inflammatory cytokines and induces apoptosis of inflammatory cells in a murine model of allergic contact dermatitis. Brit J Dermatol. 2005; 152:1235-1242.
Bhol KC, Schechter PJ. Effects of Nanocrystalline Silver (NPI 32101) in a Rat Model of Ulcerative Colitis. Dig Dis Sci. 2007 Apr 12; [Epub ahead of print]
Ghilane J, Fan FR, Bard AJ and Dunwoody N. Facile electrochemical characterization of core/shell nanoparticles. Ag core/Ag2O shell structures. Nano Lett. 2007(May);7(5):1406 - 12. [Epub 2007 Apr 3].
|
